Definitive Healthcare Corp. (NASDAQ:DH) Position Increased by Tower Research Capital LLC TRC

Tower Research Capital LLC TRC increased its stake in shares of Definitive Healthcare Corp. (NASDAQ:DH) by 599.6% in the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 5,786 shares of the company’s stock after buying an additional 4,959 shares during the quarter. Tower Research Capital LLC TRC’s holdings in Definitive Healthcare were worth $58,000 at the end of the most recent quarter.

Several other large investors have also recently added to or reduced their stakes in DH. Reynders McVeigh Capital Management LLC acquired a new stake in shares of Definitive Healthcare in the fourth quarter valued at approximately $129,000. Arizona State Retirement System increased its position in Definitive Healthcare by 13.6% in the 4th quarter. Arizona State Retirement System now owns 14,253 shares of the company’s stock valued at $142,000 after acquiring an additional 1,701 shares during the period. SG Americas Securities LLC bought a new stake in Definitive Healthcare during the 3rd quarter valued at $116,000. Zurcher Kantonalbank Zurich Cantonalbank boosted its position in Definitive Healthcare by 209.8% during the 4th quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 16,209 shares of the company’s stock worth $161,000 after acquiring an additional 10,977 shares during the period. Finally, J.P. Morgan Private Wealth Advisors LLC bought a new position in shares of Definitive Healthcare in the third quarter worth $131,000. 98.67% of the stock is owned by institutional investors and hedge funds.

Definitive Healthcare Stock Up 2.3 %

Shares of DH traded up $0.16 during trading hours on Monday, reaching $7.15. The company’s stock had a trading volume of 294,707 shares, compared to its average volume of 577,028. The company has a 50 day moving average of $8.04 and a two-hundred day moving average of $8.31. The company has a quick ratio of 2.31, a current ratio of 2.31 and a debt-to-equity ratio of 0.20. The firm has a market cap of $842.20 million, a price-to-earnings ratio of -4.02, a P/E/G ratio of 6.09 and a beta of 1.39. Definitive Healthcare Corp. has a 1-year low of $5.53 and a 1-year high of $12.45.

Definitive Healthcare (NASDAQ:DH) last issued its earnings results on Wednesday, February 28th. The company reported ($0.01) earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.01 by ($0.02). Definitive Healthcare had a negative net margin of 80.40% and a positive return on equity of 0.43%. The company had revenue of $65.93 million for the quarter, compared to analyst estimates of $66.01 million. As a group, research analysts predict that Definitive Healthcare Corp. will post 0.11 EPS for the current fiscal year.

Analyst Upgrades and Downgrades

A number of analysts have recently weighed in on the stock. Canaccord Genuity Group upped their price target on shares of Definitive Healthcare from $9.00 to $10.00 and gave the stock a “hold” rating in a research note on Thursday, February 29th. Barclays boosted their price objective on Definitive Healthcare from $10.00 to $11.00 and gave the stock an “equal weight” rating in a research note on Friday, March 1st. Canaccord Genuity Group cut Definitive Healthcare from a “buy” rating to a “hold” rating in a research note on Friday, January 5th. Stifel Nicolaus lowered their target price on Definitive Healthcare from $12.00 to $11.00 and set a “buy” rating on the stock in a report on Wednesday, January 17th. Finally, Needham & Company LLC downgraded shares of Definitive Healthcare from a “buy” rating to a “hold” rating in a report on Wednesday, January 17th. Seven analysts have rated the stock with a hold rating and two have assigned a buy rating to the company. According to data from MarketBeat.com, the stock currently has an average rating of “Hold” and a consensus target price of $11.31.

About Definitive Healthcare

Definitive Healthcare Corp., together with its subsidiaries, provides software as a service (SaaS) healthcare commercial intelligence platform in the United States and internationally. Its SaaS platform provides information on healthcare providers and their activities to help its customers from product development to go-to-market planning, and sales and marketing execution.